Diuretic Management in Hypercapnia

Introduction to Diuretic Therapy

• The American Heart Association recommends the use of loop diuretics, such as torsemide, bumetanide, or furosemide, in patients with hypercapnia, with the caveat that they can worsen metabolic alkalosis and hypercapnia 1, 2

Preferred Loop Diuretics

• The American College of Cardiology suggests that torsemide is the preferred loop diuretic due to its longest duration of action and highest oral bioavailability, with a recommended dose of 10-20 mg once daily 1, 2
• Bumetanide is an alternative option, with better oral bioavailability than furosemide, and a recommended dose of 0.5-1.0 mg once or twice daily 1, 2

Sequential Nephron Blockade

• The American Heart Association recommends considering sequential nephron blockade with metolazone 2.5-10 mg plus a loop diuretic in patients with diuretic resistance 1, 2

Monitoring and Adjustments

• The American College of Cardiology suggests monitoring for metabolic acidosis, potassium and magnesium depletion, and adjusting loop diuretic doses accordingly 1, 4

Combination Therapy

• The American Heart Association recommends combining mineralocorticoid receptor antagonists, such as spironolactone, with acetazolamide in patients with heart failure and hypercapnia, with careful potassium monitoring 1, 2